Cannabis-Related Suicide ED Visits Stayed Stable Two Years After Canadian Legalization

The profile of patients presenting to Canadian EDs with both suicidal ideation and cannabis use remained stable from immediately post-legalization to two years later, though repeat visits for suicidality increased in the earlier cohort.

Simmons, Maria et al.·BJPsych open·2025·Moderate EvidenceObservational
RTHC-07663ObservationalModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

The number of ED encounters and suicidality-related ED encounters following the index visit were significantly higher in the immediate post-legalization cohort compared to the two-years-later cohort. However, the overall patient profile remained stable despite increased cannabis use in the general population. Personality disorders were associated with repeat cannabis-related ED visits.

Key Numbers

Two cohorts compared across matched 6.5-month periods. Significantly more follow-up ED visits in the early post-legalization cohort (t=2.05, p=0.042). Significantly more suicidality-related follow-up ED visits in the early cohort (t=2.23, p=0.027). Personality disorders associated with repeat visits.

How They Did This

Retrospective chart review comparing two cohorts of patients presenting to EDs with suicidal ideation/attempts and cannabis use: October 2018-April 2019 (immediately post-legalization) and October 2020-April 2021 (two years later). ED healthcare usage tracked for 2 years before and after index encounter.

Why This Research Matters

A key concern about cannabis legalization is whether it would increase suicide-related presentations. This study from Canada provides real-world data suggesting the patient population remained stable even as legal access expanded.

The Bigger Picture

The stability of the patient profile despite rising population-level cannabis use suggests that legalization may not be dramatically changing who presents with co-occurring suicidality and cannabis use, though the early post-legalization period showed more repeat visits.

What This Study Doesn't Tell Us

Retrospective chart review with limited sample sizes. Only two EDs. Cannot establish causation between cannabis use and suicidality. COVID-19 pandemic overlapped with the second cohort, potentially confounding results. Cannabis use was self-reported during ED visits.

Questions This Raises

  • ?Did the COVID-19 pandemic affect the second cohort's ED utilization patterns?
  • ?Would longer post-legalization follow-up reveal emerging trends?

Trust & Context

Key Stat:
Evidence Grade:
Retrospective chart review with statistical analysis and longitudinal tracking, but small sample, two sites, and COVID confounding limit evidence to moderate.
Study Age:
Data from October 2018 to April 2021, spanning Canadian cannabis legalization.
Original Title:
Understanding the role of cannabis in patients with suicidal ideation presenting to the emergency department: systematic chart review.
Published In:
BJPsych open, 11(5), e199 (2025)
Database ID:
RTHC-07663

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Did cannabis legalization in Canada increase suicidal ED visits?

The patient profile remained stable over two years despite increased general population cannabis use. However, the immediate post-legalization cohort had more repeat ED visits for suicidality.

Does cannabis cause suicidal thoughts?

This study examined co-occurrence, not causation. It tracked patients who presented with both suicidal ideation and cannabis use but could not determine whether cannabis contributed to their suicidality.

Read More on RethinkTHC

Cite This Study

RTHC-07663·https://rethinkthc.com/research/RTHC-07663

APA

Simmons, Maria; Crocker, Candice E; Fisher, Derek; Stewart, Sherry H; Emsley, Jason G; Abidi, Sabina; Carter, Alix; Calkin, Cynthia; Yakovenko, Igor; Magee, Kirk; Tibbo, Philip G. (2025). Understanding the role of cannabis in patients with suicidal ideation presenting to the emergency department: systematic chart review.. BJPsych open, 11(5), e199. https://doi.org/10.1192/bjo.2025.10776

MLA

Simmons, Maria, et al. "Understanding the role of cannabis in patients with suicidal ideation presenting to the emergency department: systematic chart review.." BJPsych open, 2025. https://doi.org/10.1192/bjo.2025.10776

RethinkTHC

RethinkTHC Research Database. "Understanding the role of cannabis in patients with suicidal..." RTHC-07663. Retrieved from https://rethinkthc.com/research/simmons-2025-understanding-the-role-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.